Themis Medicare Ltd

NSE
THEMISMED •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or open an account for live prices.
Start SIP in Themis Medicare Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
61.04% Gain from 52W Low
9.7
TTM PE Ratio
Below industry Median
48.4
Price to Book Ratio
Above industry Median
5.6
Dividend yield 1yr %
Below industry Median
0.4
TTM PEG Ratio
PEG TTM is negative
-2.1
RSI
RSI is mid-range
58.1
MFI
MFI is mid-range
66.1

Themis Medicare Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Themis Medicare Ltd shareholding Pattern

Promoter
67.2%
Public
32.8%
Promoter
67.2%
Public
32.8%
Promoter
67.2%
Public
32.8%
Promoter
67.2%
Public
32.8%
Promoter
67.2%
Public
32.8%
Promoter
67.2%
Foreign Institutions
0.1%
Public
32.8%

Themis Medicare Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
5Day EMA
227.50
10Day EMA
225.00
12Day EMA
224.00
20Day EMA
221.10
26Day EMA
219.70
50Day EMA
217.30
100Day EMA
214.40
200Day EMA
202.40
5Day SMA
228.50
10Day SMA
223.90
20Day SMA
219.50
30Day SMA
217.10
50Day SMA
213.70
100Day SMA
219.40
150Day SMA
217.10
200Day SMA
204.50
Delivery & Volume
Resistance & Support
228.76
Pivot
Resistance
First Resistance
231.79
Second Resistance
234.90
Third Resistance
237.93
Support
First Support
225.65
Second support
222.62
Third Support
219.51
Relative Strength Index
58.07
Money Flow Index
66.10
MACD
4.29
MACD Signal
3.06
Average True Range
10.10
Average Directional Index
12.51
Rate of Change (21)
4
Rate of Change (125)
5.89
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Amrutanjan Health Care Ltd.
2147.92
563.9
825.15
SMS Pharmaceuticals Ltd.
2085.15
100.8
263.73
Hester Biosciences Ltd.
2437.34
1292.85
2875
NGL Fine - Chem Ltd.
1677.53
1728.1
2823.9
Solara Active Pharma Sciences Ltd.
2035.2
263.55
639.7
Sigachi Industries Ltd.
1976.06
29.08
95.9

Themis Medicare Ltd Company background

Founded in: 1969
Managing director: Sachin D Patel
Incorporated in 1969, Themis Medicare Ltd., formerly known as Themis Chemicals (TCL) was originally promoted by Chemosyn and Medimpex but was taken over by a Group consisting of Shantibhai D Patel and K T Lakdawala who also have interests in Andhra Synthetics and Antibiotics, which was merged with Artemis Pharmaceuticals in April 93. The Group is principally engaged in the activities pertaining to manufacturing of pharmaceutical products, especially in Formulation and API activity.In Mar.95, the company came out with a public issue equity shares (premium : Rs 110) to finance the expansioncummodernisation of its synthetic bulk drug plant at Vapi, the setting up of a formulation unit at Lilora, Baroda as backward integration and to augment longterm working capital.Total cost of the project was estimated at Rs 17.64 cr. TCL manufactures and sells synthetic bulk drugs and formulations. It operates in the therapeutic segments of antituberculosis, cerebroactivators, bronchodilators, antiasthmatic, anaesthetic and other segments.Antituberculosis bulk drugs and formulations account for 60% of its turnover and the company is rated fourth in terms of turnover in this segment. TCL has also started manufacturing and exporting fumagillin, an antibacterial drug, for veterinary use for which it has a confirmed buyback arrangement with Chinoin, Hungary.The company with the help of M/s Pharmograd,Moscow a manufacturing unit, is planning to market its AntiT.B.formulation products through the collborators throughout the Russian Federation for trade,tenders and govt.supplies.The Company introduced products like Cardiac and Muscular Relaxant during the year 200102. A wholly owned subsidiary of the Company, Themis Medicare Singapore Pte. Ltd., formed on 22nd May, 2002 in Singapore became operational during the year 200203. M/s. Artemis Biotech Ltd., a Group Company was merged with Themis Medicare Ltd. (the Parent Company) with effect from 1st April 2003. The Joint Venture Company, Richter Themis Medicare (India) Pvt. Ltd. started manufacturing activities at its EOU unit at Vapi effective from March, 2006. The Company started operations of its new Injection Plant at Haridwar for tablets and gel formulation production in 200607. Themiseal, the Companys unique haemostatic and antimicrobial product was launched in the UK, Greece, Cyprus, Jordan, Romania and Indonesia.During the year 201011, a Private Ltd Subsidiary Company in the name and style of Themis Lifestyle Pvt. Ltd was incorporated on 3rd November, 2010 and another Public Ltd Subsidiary Company in the name and style of Artemis Biotech Ltd. was incorporated on 14th January, 2011.During FY 201617, HIDPUL KFT (Hungary), a Wholly Owned Subsidiary of the Company, ceased to be a subsidiary of the Company. Carpo Medical Limited was incorporated as a Joint Venture Company in the United Kingdom in 201617.
Read More

Themis Medicare Ltd FAQs

Themis Medicare Ltd shares are currently priced at 228.68 on NSE and 228.8 on BSE as of 7/15/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Themis Medicare Ltd [THEMISMED] share was 52.96. The Themis Medicare Ltd [THEMISMED] share hit a 1-year low of Rs. 142 and a 1-year high of Rs. 263.85.

The market cap of Themis Medicare Ltd is Rs. 2104.77 Cr. as of 7/15/2024 12:00:00 AM.

The PE ratios of Themis Medicare Ltd is 85.06 as of 7/15/2024 12:00:00 AM.

The PB ratios of Themis Medicare Ltd is 7.86 as of 7/15/2024 12:00:00 AM

You can easily buy Themis Medicare Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -